<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="475">
  <stage>Registered</stage>
  <submitdate>9/09/2005</submitdate>
  <approvaldate>14/09/2005</approvaldate>
  <actrnumber>ACTRN12605000405617</actrnumber>
  <trial_identification>
    <studytitle>Fluid responsiveness after cardiac surgery</studytitle>
    <scientifictitle>Bedside prediction of fluid responsiveness in mechanically ventilated patients following coronary artery bypass grafting.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Patients admitted to the Intensive Care Unit following Coronary Artery Bypass Grafting (CABG).</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Brain natriuretic peptide assay, transthoracic and transoesophageal echocardiography, clinical data and waveform analysis (including PaOP, CVP, pulse pressure variation and systolic pressure variation) will be performed immediately before and after rapid infusion of intravenous colloid solution.</interventions>
    <comparator>Not applicable</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>An increase in mean cardiac output, as determined by pulmonary artery catheter thermodilution, by equal to or greater than 10% within half an hour of rapid intravenous fluid administration compared with immediately before fluid administration.</outcome>
      <timepoint>30 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The impact of varying positive end expiratory pressure (PEEP).</outcome>
      <timepoint>Preload and afterload upon measured variables will be assessed.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patient booked for CABG surgery.Left ventricular ejection fraction greater than 40% pre-operatively (as determined by echocardiography or radiocontrast ventriculography).Normal cardiac valvular function (defined as mitral or aortic valve regurgitation less than 2+ on echocardiography).Normal respiratory function (defined as absence of documented respiratory pathology or FEV1/FVC greater than or equal to 60%).Absence of oesophageal pathology that would contraindicate transoesophageal echocardiography.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>ECG demonstrates rhythm other than sinus rhythm or AAI pacing post-operatively.Pulmonary hypertension (defined as pulmonary systolic blood pressure greater than 50mmHg as estimated by echocardiography pre-operatively or by pulmonary artery catheter at the time of insertion).Blood loss greater than 250mL in the first hour post-operatively.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>8/11/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Queensland</primarysponsorname>
    <primarysponsoraddress>The University of Queensland, Brisbane, Queensland, Australia 4072</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Queensland</fundingname>
      <fundingaddress>St Lucia, Queensland, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Queensland Health (Princess Alexandra Hospital)</fundingname>
      <fundingaddress>Woolloongabba, Queensland, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Princess Alexandra Hospital</sponsorname>
      <sponsoraddress>Woolloongabba, Queensland, Australia</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr David Sturgess</name>
      <address>School of Medicine
Southern Division
University of Queensland
Princess Alexandra Hospital
Ipswich Road
Woolloongabba QLD 4102</address>
      <phone>+61 7 32402111</phone>
      <fax />
      <email>s3316247@student.uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr David Sturgess</name>
      <address>School of Medicine
Southern Division
University of Queensland
Princess Alexandra Hospital
Ipswich Road
Woolloongabba QLD 4102</address>
      <phone>+61 7 32402111</phone>
      <fax />
      <email>s3316247@student.uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>